Literature DB >> 22245101

Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?

Joon Wee Ho1, Santhanam Sundar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22245101     DOI： 10.1016/j.clgc.2011.11.004

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  4 in total

Review 1.  Severe and refractory hypocalcaemia secondary to osteoblastic bone metastases in bladder signet ring carcinoma: A case report and literature review.

Authors:  Wanling Zeng; Du Soon Swee
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 2.  Hypercalcaemia and hypocalcaemia: finding the balance.

Authors:  Jean-Jacques Body; Daniela Niepel; Giuseppe Tonini
Journal:  Support Care Cancer       Date:  2017-01-12       Impact factor: 3.603

3.  Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report.

Authors:  Abdulmohsen H Al Elq
Journal:  Oman Med J       Date:  2013-03

4.  Supplement With Calcium or Alendronate Suppresses Osteopenia Due to Long Term Rabeprazole Treatment in Female Mice: Influence on Bone TRAP and Osteopontin Levels.

Authors:  Aly A M Shaalan; Mohamed El-Sherbiny; Taghrid B El-Abaseri; Mohamed Z Shoaeir; Tarek M Abdel-Aziz; Magda I Mohamed; Sawsan A Zaitone; Hala M F Mohammad
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.